Sanjay Revankar, MD

Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-106) Exploration of a Desirability of Outcome Ranking (DOOR) Endpoint for Invasive Aspergillosis Using Two Registrational Trials
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET